ライフサイエンスコーパス: wedge pressure

1 ly used variables (i.e. mixed venous oxygen, wedge pressure).

2 rdiac filling pressures (pulmonary capillary wedge pressure).

3 patient age, and varying pulmonary capillary wedge pressure.

4 pressure, heart rate, or pulmonary capillary wedge pressure.

5 orse symptoms and higher pulmonary capillary wedge pressure.

6 and severity of emphysema, and directly with wedge pressure.

7 ar resistance as well as pulmonary capillary wedge pressure.

8 ar systolic pressure and pulmonary capillary wedge pressure.

9 nary artery pressure and pulmonary capillary wedge pressure.

10 elocities for estimating pulmonary capillary wedge pressure.

11 nary artery pressure and pulmonary capillary wedge pressure.

12 ic filling, despite high pulmonary capillary wedge pressure.

13 lmonary artery pressure and pulmonary artery wedge pressure.

14 ctional flow reserve and increasing coronary wedge pressure.

15 ltaneous measurements of pulmonary capillary wedge pressure.

16 ction in mean pulmonary artery and pulmonary wedge pressures.

17 nge systemic arterial or pulmonary capillary wedge pressures.

18 42; median RAP, 4 mm Hg; pulmonary capillary wedge pressure, 11 mm Hg), those with a low JV distensib

19 t, 11.4+/-3.3 L/min; and pulmonary capillary wedge pressure, 13+/-4 mm Hg.

20 e >240 dyn-sec/cm(-5) , and pulmonary artery wedge pressure 15 mm Hg without another cause of pulmona

21 ong them, 26 (6.5%) had a pulmonary arterial wedge pressure 15 mm Hg, and 18 (4.5%) had a pulmonary a

22 was defined according to pulmonary capillary wedge pressure ( 15 mm Hg at rest or 25 mm Hg during exe

23 in, p < 0.01), increased pulmonary capillary wedge pressure (17 +/- 7 vs. 14 +/- 6 mm Hg, p < 0.002)

24 g; P=0.0002), and higher pulmonary capillary wedge pressure (17+/-5 versus 9+/-3 mm Hg; P=0.0001).

25 m Hg to 98 +/- 13 mm Hg; pulmonary capillary wedge pressure: 17 +/- 6 mm Hg to 21 +/- 7 mm Hg; cardia

26 s. 108 +/- 14 mm Hg) and pulmonary capillary wedge pressure (18 +/- 2 vs. 12 +/- 4 mm Hg) versus prei

27 -4 mm Hg; P=0.0001), and pulmonary capillary wedge pressure (18+/-5 versus 10+/-4 mm Hg; P<0.0001) co

28 mg significantly reduced pulmonary capillary wedge pressure (-2.6+/-0.7, -5.4+/-0.7, and -4.6+/-0.7 m

29 tric LVH and estimated mean pulmonary artery wedge pressure (20 mm Hg vs. 16 mm Hg) and shorter isovo

30 p < 0.01 by ANOVA) and mean pulmonary artery wedge pressure (21+/-3 to 16+/-2 mm Hg, p < 0.05 by ANOV

31 58; median RAP, 8 mm Hg; pulmonary capillary wedge pressure, 22 mm Hg; P<0.0001 for both) were more l

32 arly reductions were sustained for pulmonary wedge pressure (24+/-9 to 15+/-5 mm Hg early; 12+/-6 mm

33 +/-2 mm Hg; P<0.05), and pulmonary capillary wedge pressure (25+/-2 to 20+/-2 mm Hg; P<0.05).

34 produced significant reductions in pulmonary wedge pressure (27% to 39% decrease by 6 h), mean right

35 s. 16 +/- 8 mm Hg, p = 0.007, mean pulmonary wedge pressure: 27 +/- 8 mm Hg vs. 20 +/- 7 mm Hg, p = 0

36 s. 13 mm Hg; p = 0.001), pulmonary capillary wedge pressure (29 vs. 24 mm Hg; p = 0.001), but similar

37 with lower mean exercise pulmonary capillary wedge pressure (-3 mm Hg [95% CI, -5 to -1] ) and higher

38 pressure (18+/-2 to 7+/-1 mm Hg), pulmonary wedge pressure (32+/-3 to 15+/-2 mm Hg), and systemic va

39 vascular resistance 25%, pulmonary capillary wedge pressure 33%, and central venous pressure 27% whil

40 nitrite reduced resting pulmonary capillary wedge pressure (-4+/-3 versus -1+/-2 mm Hg; P=0.002), im

41 uctions in 0-hour trough pulmonary capillary wedge pressure (-4.3 mm Hg; P=0.16), pulmonary artery di

42 sulted in an increase in pulmonary capillary wedge pressure (54 +/- 78% vs. 32 +/- 26%, p = NS), card

43 es significantly reduced pulmonary capillary wedge pressure (-6.4 +/- 4.1 mm Hg, -5.7 +/- 4.6 mm Hg,

44 icacy end point included pulmonary capillary wedge pressure (72 to 96 hours) and days alive out of ho

45 iameter, 3.53+/-0.51 cm; pulmonary capillary wedge pressure, 8.1+/-3.1 mm Hg; pulmonary artery satura

46 , thermodilution CI, and pulmonary capillary wedge pressure alone.

47 of ADMA correlated with pulmonary capillary wedge pressure and both systolic and diastolic pulmonary

48 monary arterial pressure, pulmonary arterial wedge pressure and cardiac output.

49 e actual R(micro) and IMR after the coronary wedge pressure and collateral flow were incorporated int

50 tment markedly decreased pulmonary capillary wedge pressure and improved pressure-flow relationship.

51 -confirmed PH with elevated pulmonary artery wedge pressure and low pulmonary vascular resistance, we

52 ight atrial pressure and pulmonary capillary wedge pressure and lower cardiac index (CI) but not Paco

53 Pulmonary capillary wedge pressure and LV end-diastolic pressure were signif

54 ssure-volume curves from pulmonary capillary wedge pressure and LV end-diastolic volume and Starling

55 Pulmonary capillary wedge pressure and LV end-diastolic volume were measured

56 d normative responses of pulmonary capillary wedge pressure and mean pulmonary arterial pressure to v

57 the largest increases in pulmonary capillary wedge pressure and mean pulmonary arterial pressure.

58 the presence of a normal pulmonary capillary wedge pressure and portal hypertension, is a known compl

59 dose-dependently reduced pulmonary capillary wedge pressure and pulmonary and systemic vascular resis

60 ulmonary exercise tests, pulmonary capillary wedge pressure and serum sodium were strong predictors o

61 hemodynamics in AMI-VSD, pulmonary capillary wedge pressure and shunting were worsened by extracorpor

62 ane oxygenation worsened pulmonary capillary wedge pressure and shunting, which could be improved by

63 and Starling curves from pulmonary capillary wedge pressure and SV during lower body negative pressur

64 c output, stroke volume, pulmonary capillary wedge pressure and systemic vascular resistance.

65 ary artery catheter use, pulmonary capillary wedge pressure and the incidence of diabetes mellitus an

66 d significant inverse correlations with mean wedge pressure and time constant of LV relaxation.

67 placement therapy, lower pulmonary capillary wedge pressure and vasoactive-inotropic score, and highe

68 Pulmonary capillary wedge pressures and left ventricular end-diastolic volum

69 Pulmonary capillary wedge pressures and LV end-diastolic volumes were measur

70 re, pulmonary vascular resistance, capillary wedge pressure, and cardiac index were also obtained at

71 Increased cardiac output, decreased wedge pressure, and decreased brain natriuretic peptide

72 d right atrial pressure, pulmonary capillary wedge pressure, and pulmonary hypertension, respectively

73 cardiac output, decrease pulmonary capillary wedge pressure, and reduce pulmonary and systemic vascul

74 cardiac index, elevated pulmonary capillary wedge pressure, and renal impairment or substantial diur

75 ons include: (1) liver biopsy, portal venous wedge pressure, and reversal of portal venous flow on Do

76 Primary end point was pulmonary capillary wedge pressure, and secondary end points comprised cardi

77 diac output, heart rate, pulmonary capillary wedge pressure, and systemic vascular resistance were me

78 alculated values such as pulmonary capillary wedge pressure, aortic pulsatility index, and cardiac in

79 Higher pulmonary capillary wedge pressure appears to enhance net right ventricular

80 s that pulmonary artery and pulmonary artery wedge pressures are higher in SIPE-susceptible individua

81 tly greater reduction in pulmonary capillary wedge pressure at 3, 4, and 8 hours and during the presp

82 was no effect of age on pulmonary capillary wedge pressure at any point throughout the cardiac cycle

83 r than 40%, and a raised pulmonary capillary wedge pressure at rest (>15 mm Hg) or during exercise (>

84 e were no differences in pulmonary capillary wedge pressure at rest (13+/-4 versus 13+/-3 mm Hg, P=0.

85 d with directly measured pulmonary capillary wedge pressure at rest (r=0.63, P<0.0001) and during exe

86 our period and decreased pulmonary capillary wedge pressure at rest by 1 mm Hg (95% CI, -2 to 0) and

87 with HFpEF (n=34; median pulmonary capillary wedge pressure at rest, 13 mm Hg; at stress, 27 mm Hg) h

88 ients had a reduction in pulmonary capillary wedge pressure at rest, 34 (58%) of 59 had a lower pulmo

89 y be changed by elevated pulmonary capillary wedge pressure, augmenting right ventricular pulsatile l

90 ose-related decreases in pulmonary capillary wedge pressure (average change -5.9+/-0.9 mm Hg and -5.3

91 Overall, the mean pulmonary capillary wedge pressure before LVAD implantation was 25+/-9 mm Hg

92 d pressure, and baseline pulmonary capillary wedge pressure between groups (eg, pulmonary capillary w

93 ulmonary artery pressure or pulmonary artery wedge pressure between SIPE-susceptible subjects and con

94 er increases in exercise pulmonary capillary wedge pressure (both P<0.0001).

95 roving cardiac index and pulmonary capillary wedge pressure, but statistical significance for the pri

96 ram per minute decreased pulmonary-capillary wedge pressure by 6.0 and 9.6 mm Hg, respectively (as co

97 systemic blood pressure, pulmonary capillary wedge pressure, cardiac index, and estimated glomerular

98 mean arterial pressure, pulmonary capillary wedge pressure, cardiac index, or systemic vascular resi

99 gnificant differences in pulmonary capillary wedge pressure, cardiac output, pulmonary vascular resis

100 artery, right atrial and pulmonary capillary wedge pressures, cardiac index, systemic and pulmonary v

101 al, pulmonary artery, or pulmonary capillary wedge pressures; cardiac index; respiratory rate; or hea

102 11; LVAD, 18+/-4 mm Hg) and pulmonary artery wedge pressure (CHF, 16+/-10; LVAD 5+/-3 mm Hg) were red

103 , 30+/-5 mm Hg) and mean pulmonary capillary wedge pressure (CHF, 31+/-11; LVAD, 14+/-6 mm Hg) were l

104 ated LV end-diastolic or pulmonary capillary wedge pressure, consistent with diastolic dysfunction, w

105 as the inverse was true for pulmonary artery wedge pressure (corresponding muPAWP were 21.5, 16.5, an

106 d using rest or exercise pulmonary capillary wedge pressure criteria (>=15 mm Hg or Deltapulmonary ca

107 (-2)]; P<0.001) and mean pulmonary capillary wedge pressure decreased (from 15 mm Hg [IQR, 12-20 mm H

108 48 hours after implant, pulmonary capillary wedge pressure decreased 44%, systemic vascular resistan

109 decreased 19% (P=0.03), pulmonary capillary wedge pressure decreased 46% (P=0.002), and mean arteria

110 iac index increased 43%, pulmonary capillary wedge pressure decreased 52%, systemic vascular resistan

111 +/-5 mm Hg, P<0.001) and pulmonary capillary wedge pressure decreased by 27% (31+/-8 versus 22+/-9 mm

112 The pulmonary wedge pressure decreased during exercise, consistent wit

113 25.9 +/- 1.7 mm Hg; mean pulmonary capillary wedge pressure decreased from 25.1 +/- 1.1 to 13.2 +/- 1

114 Pulmonary capillary wedge pressure decreased from 28.5+/-4.9 to 19.8+/-7.0 m

115 Pulmonary capillary wedge pressure decreased from 28.8+/-6.3 mm Hg (mean+/-S

116 Pulmonary capillary wedge pressure* decreased to a larger extent with F+T th

117 flow relationship (Delta pulmonary capillary wedge pressure/Delta cardiac output) significantly durin

118 eria (>=15 mm Hg or Deltapulmonary capillary wedge pressure/Deltacardiac output slope, >2.0 mm Hg.L(-

119 sion (n=1009) and normal pulmonary capillary wedge pressure displayed a consistent R(PA)-C(PA) hyperb

120 of aortic, right atrial, and distal coronary wedge pressure during balloon occlusion.

121 elated with reduction in pulmonary capillary wedge pressure during exercise (r=0.56, P<0.001).

122 ion of at least 40%, and pulmonary capillary wedge pressure during exercise of at least 25 mm Hg whil

123 rimary end point was the pulmonary capillary wedge pressure during exercise.

124 (58%) of 59 had a lower pulmonary capillary wedge pressure during exertion, and 23 (39%) of 59 fulfi

125 (9+/-2 mm Hg) displayed pulmonary capillary wedge pressure elevation (P=0.03).

126 Exercise elicits greater pulmonary capillary wedge pressure elevation compared with saline in HFpEF b

127 Mean pulmonary wedge pressure fell from 31 to 18 mm Hg, right atrial pr

128 p < 0.01) and increased pulmonary capillary wedge pressure (from 25 +/- 2 to 29 +/- 3 mm Hg, p < 0.0

129 is predictive of a mean pulmonary capillary wedge pressure greater than 15 mm Hg with a 92% sensitiv

130 ction 21+/-1%) who had a pulmonary capillary wedge pressure >/=15 mm Hg and a cardiac index </=2.5 L

131 Patients with a baseline pulmonary capillary wedge pressure >/=15 mm Hg and a cardiac index </=2.5 L.

132 ventricular [RV] DD) or pulmonary capillary wedge pressure >/=18 mm Hg (left ventricular [LV] DD) wi

133 pressure <100 mm Hg and pulmonary capillary wedge pressure >/=24 mm Hg and dependent on >/=2 inotrop

134 ients in MI+DD (29%) had pulmonary capillary wedge pressure >15 (14+/-4 mm Hg), whereas none of the M

135 identified patients with pulmonary capillary wedge pressure >15 mm Hg (area under the curve: 0.73 to

136 ssified as cold and wet (pulmonary capillary wedge pressure >15 mm Hg) and cold and dry (pulmonary ca

137 m Hg, and 18 (4.5%) had a pulmonary arterial wedge pressure >15 mm Hg.

138 ubgroups: (1) patients with pulmonary artery wedge pressure >15 mm Hg; (2) pulmonary vascular resista

139 ic balloon pump support, pulmonary capillary wedge pressure >20 mm Hg and serum creatinine >1.5 mg/dl

140 lvement evident at rest (pulmonary capillary wedge pressure >=15 mm Hg; area under the curve, 0.81 ve

141 exercise stress induced pulmonary capillary wedge pressure >=25 mm Hg (area under the curve, 0.79 ve

142 on class II-IV, elevated pulmonary capillary wedge pressure (>/=15 mm Hg at rest or >/=25 mm Hg durin

143 ise, an abnormal rise in pulmonary capillary wedge pressure (>25 mm Hg) was observed in 94% of MI+DD

144 80% of predicted and peak pulmonary arterial wedge pressure>/=20 mm Hg) with 31 age- and sex-matched

145 y, ratio of right atrial/pulmonary capillary wedge pressure, hemoglobin) was created.

146 fter adjusting for exercise pulmonary artery wedge pressure (HR 2.08 per WU.m2, 95% CI 1.19-3.62; P =

147 0.022), diastolic PAP - pulmonary capillary wedge pressure (HR, 2.19; 95% CI, 1.23-3.89 per 10 mm Hg

148 eart failure to decrease pulmonary capillary wedge pressure, improve cardiac output, stimulate natriu

149 The mean pulmonary capillary wedge pressure in patients with PHTN was higher than tha

150 In healthy subjects, pulmonary capillary wedge pressure increased from 10+/-2 to 16+/-3 mm Hg aft

151 Mean pulmonary capillary wedge pressure increased from 9.3 +/- 3.2 mm Hg to 10.6

152 y arterial pressure, and pulmonary capillary wedge pressure increased similarly with saline and exerc

153 Right atrial and pulmonary capillary wedge pressures increased from 6 +/- 4 and 5 +/- 3 mm Hg

154 rease stroke volume when pulmonary capillary wedge pressure is lowered with vasodilators.

155 volume overload, a treatment-induced drop in wedge pressure is often accompanied by a rapid drop in N

156 ch as ejection fraction, cardiac output, and wedge pressure, is available, but also in clinical trial

157 d-diastolic pressures and pulmonary arterial wedge pressures, is associated with remarkably increased

158 The pulmonary capillary wedge pressure, lactic acid level, and creatinine level

159 ndex, ejection fraction, pulmonary capillary wedge pressure, left ventricular dimensions, watts achie

160 power output and higher pulmonary capillary wedge pressure, less likely to receive vasopressors or t

161 s x second x cm(-5), and pulmonary capillary wedge pressure < or = 15 mm Hg.

162 pressure >/=25 mm Hg and pulmonary capillary wedge pressure </=15 mm Hg at right heart catheterizatio

163 crimination between mean pulmonary capillary wedge pressure </=15 versus >15 mm Hg.

164 pressure >/=25 mm Hg and pulmonary capillary wedge pressure </=15mm Hg).

165 nous pressure <12 mm Hg, pulmonary capillary wedge pressure <18 mm Hg, and cardiac index >2.2 L/(min.

166 furosemide, mannitol (if pulmonary capillary wedge pressure <20 mm Hg), and low-dose dopamine (n = 43

167 e >240 dyn-sec/cm(-5) , and pulmonary artery wedge pressure <=15 mm Hg without another cause of pulmo

168 mm Hg) and cold and dry (pulmonary capillary wedge pressure <=15 mm Hg) based on pre-LVAD hemodynamic

169 scular resistance, >3.0 WU; pulmonary artery wedge pressure, </=15 mm Hg).

170 sure between groups (eg, pulmonary capillary wedge pressure: LVH, 13.4+/-2.7 versus control, 11.7+/-1

171 tage have revealed a normal pulmonary artery wedge pressure, marked elevation of pulmonary artery pre

172 hemodynamic performance with lower pulmonary wedge pressure (mean difference, 2.23 mm Hg [95% CI, 0.4

173 the true IMR (IMR(true)), which incorporates wedge pressure measurement to account for collateral flo

174 th Revision procedure codes describing PA or wedge-pressure monitoring, measurement of mixed venous b

175 Mean pulmonary arterial wedge pressure (mPAWP) and left ventricular end-diastoli

176 mic severity is the mean Pulmonary Capillary Wedge Pressure (mPCWP), which is ideally measured invasi

177 FpEF by rest or exercise pulmonary capillary wedge pressure (n=12) or exercise criteria (n=12).

178 owever, elevation of the pulmonary capillary wedge pressure (n=8142) had a larger impact, significant

179 A pulmonary capillary wedge pressure of >=15 mm Hg indicated congestion, terme

180 versus 32 +/- 12%) and mean pulmonary artery wedge pressure of < or = 18 versus > 18 mm Hg (84 +/- 6%

181 wo post-CBC variables: mean pulmonary artery wedge pressure of < or = 18 versus > 18 mm Hg (90 +/- 6%

182 dex (2.4 liters/min.m2), pulmonary capillary wedge pressure of 16 +/- 9 mm Hg (mean +/- SD) and maxim

183 ter, 127 patients with a pulmonary-capillary wedge pressure of 18 mm Hg or higher and a cardiac index

184 re of 40.5+/-11.4 mm Hg, pulmonary capillary wedge pressure of 22.6+/-8.9 mm Hg, and pulmonary vascul

185 x of 1.7 L/min per m(2), pulmonary capillary wedge pressure of 25.6 mm Hg, and left ventricular eject

186 c filling volume was the pulmonary capillary wedge pressure of the seniors lower than that of the you

187 839]; P < 0.001), estimated pulmonary artery wedge pressure (OR, 1.437; 95% CI [1.131-2.274]; P < 0.0

188 ic pressure (P = 0.001) and pulmonary artery wedge pressure (P = 0.009).

189 0.02, r = 0.83), higher pulmonary capillary wedge pressure (p = 0.01, r = 0.58) and lower cardiac in

190 08, r = 0.88) and higher pulmonary capillary wedge pressure (p = 0.02, r =0.54).

191 kload corrected exercise pulmonary capillary wedge pressure (P<0.01).

192 al pressure (P=0.36) and pulmonary capillary wedge pressure (P=0.53) were not.

193 y reduced pulmonary arterial (p < 0.001) and wedge pressures (p < 0.01) and pulmonary vascular resist

194 dynamic profiles, including higher pulmonary wedge pressures (P=0.002) and lower cardiac indexes (P<0

195 dilatation, increase of pulmonary capillary wedge pressure, PAP and RAP were more pronounced in AF t

196 fraction was defined as a pulmonary arterial wedge pressure (PAWP) >=15 mmHg (rest) or >=25 mmHg (exe

197 related to the use of mean pulmonary artery wedge pressure (PAWP).

198 ly correlated with supine pulmonary arterial wedge pressure (PAWP; r=0.36; P<0.001) and demonstrated

199 isease (PH(PVD), defined as pulmonary artery wedge pressure [PAWP]</=15 mm Hg and PVR>3 WU).

200 PEEP can dissociate wedge pressure (Pcw) from transmural left atrial pressur

201 intraarterial catheter, pulmonary capillary wedge pressure (Pcw), continuous cardiac output (Q), and

202 =2.5 l/min per m(2) and pulmonary capillary wedge pressure (PCWP) > or =15 mm Hg) who were admitted

203 ssure (RAP) >12 mm Hg or pulmonary capillary wedge pressure (PCWP) >15 mm Hg were analyzed.

204 nine (2.6 to 1.5 mg/dL), pulmonary capillary wedge pressure (PCWP) (32 to 14 mm Hg), and right atrial

205 by baseline measures of pulmonary capillary wedge pressure (PCWP) and cardiac index (CI), and by cha

206 ficant increases in both pulmonary capillary wedge pressure (PCWP) and central venous pressure (CVP).

207 sitive relationship with pulmonary capillary wedge pressure (PCWP) and left ventricular end-diastolic

208 al capacity, and dynamic pulmonary capillary wedge pressure (PCWP) and right atrial pressure response

209 ns were observed between pulmonary capillary wedge pressure (PCWP) and sole parameters of mitral flow

210 subjects for measures of pulmonary capillary wedge pressure (PCWP) and SV (thermodilution derived car

211 trial pressure (RAP) and pulmonary capillary wedge pressure (PCWP) are correlated in heart failure, i

212 n the prospective group, pulmonary capillary wedge pressure (PCWP) derived as: PCWP(Doppler) = LV(end

213 hy, BNP measurement, and pulmonary capillary wedge pressure (PCWP) determination.

214 Increases in pulmonary capillary wedge pressure (PCWP) develop in patients with HFpEF dur

215 ere, we examined whether pulmonary capillary wedge pressure (PCWP) during a passive leg raise (PLR) c

216 A marked rise in pulmonary capillary wedge pressure (PCWP) during exertion is pathognomonic f

217 has been correlated with pulmonary capillary wedge pressure (PCWP) in a wide variety of cardiac condi

218 s noninvasive markers of pulmonary capillary wedge pressure (PCWP) in the setting of critical illness

219 During exercise, pulmonary capillary wedge pressure (PCWP) increased markedly and to similar

220 y measured peak exercise pulmonary capillary wedge pressure (PCWP) of 25 mm Hg or greater were includ

221 ity of life, and dynamic pulmonary capillary wedge pressure (PCWP) responses were compared between th

222 invasive measurement of pulmonary capillary wedge pressure (PCWP) simultaneous with Doppler echocard

223 d ePVH groups had higher pulmonary capillary wedge pressure (PCWP) than the ePH group (P < 0.05).

224 ary outcome was ratio of pulmonary capillary wedge pressure (PCWP) to cardiac index (CI) at peak exer

225 Pulmonary capillary wedge pressure (PCWP) was estimated from the ratio of ea

226 ary artery pressure, and pulmonary capillary wedge pressure (PCWP) were recorded.

227 27% (n=161) had elevated pulmonary capillary wedge pressure (PCWP) with postcapillary pulmonary hyper

228 tery pressure>=32 mm Hg, pulmonary capillary wedge pressure (PCWP)>=20 mm Hg, and pulmonary vascular

229 ion fraction, 22 +/- 9%; pulmonary capillary wedge pressure (PCWP), 16 +/- 10 mm Hg; cardiac index (C

230 c nerve activity (RSNA), pulmonary capillary wedge pressure (PCWP), and mean arterial pressure (MAP)

231 in eight males from whom pulmonary capillary wedge pressure (PCWP), central venous pressure and SV (v

232 ressure, as expressed by pulmonary capillary wedge pressure (PCWP), during lower-body negative pressu

233 as associated with lower pulmonary capillary wedge pressure (PCWP), fewer symptoms, and greater quali

234 We measured pulmonary capillary wedge pressure (PCWP), SV, left ventricular end-diastoli

235 es of istaroxime lowered pulmonary capillary wedge pressure (PCWP), the primary end point (mean +/- S

236 cant relations with mean pulmonary capillary wedge pressure (PCWP).

237 etween the reductions in pulmonary capillary wedge pressure (PCWP; 25.4, 24.6, 24.0, 23.5, 23.4, 21.5

238 ardiographic indices and pulmonary capillary wedge pressures (PCWP) in normal volunteers.

239 Hg and LV congestion if pulmonary capillary wedge pressure [PCWP] 22 mm Hg) categorizations was the

240 concomitant increase in the pulmonary artery wedge pressure per increase in cardiac output >2 mm Hg/L

241 th a higher increase in the pulmonary artery wedge pressure per increase in cardiac output ratio.

242 Pulmonary capillary wedge pressure, pulmonary arterial pressure, stroke volu

243 y linear regression with pulmonary capillary wedge pressure (pw).

244 rom pulmonary venous hypertension (PVH) by a wedge pressure (PWP)>15 mm Hg in PVH.

245 aphic severity correlated significantly with wedge pressure (r = 0.93, P < .001) and pulmonary arteri

246 correlated with invasive pulmonary arterial wedge pressure (r(2)=0.57, root mean square error 5.0 mm

247 rong inverse relation with PVR (r=-0.64) and wedge pressure (r=-0.73), and provides stronger predicti

248 tly with changes in mean pulmonary capillary wedge pressure (r=0.63, P<0.001).

249 VR) ratio had the best correlation with mean wedge pressure (r=0.79, P<0.001), as well as in 24 prosp

250 els correlated with mean pulmonary capillary wedge pressure (r=0.82, P=0.007).

251 01), higher right atrium:pulmonary capillary wedge pressure ratio (beta, 0.25; SE, 0.01; P<0.001), an

252 nd right atrial pressure/pulmonary capillary wedge pressure ratio were most associated with worsened

253 x, right atrial pressure:pulmonary capillary wedge pressure ratio, RV stroke work index).

254 d the greatest degree of pulmonary capillary wedge pressure reductions and decreased left-to-right sh

255 aturation percentage and pulmonary capillary wedge pressure relate to cardiac output and congestion,

256 ed a steeper increase in pulmonary capillary wedge pressure relative to infused volume (25+/-12 mm Hg

257 ed a steeper increase in pulmonary capillary wedge pressure relative to volume infused (16+/-4 mm Hg.

258 n mean pulmonary artery and pulmonary artery wedge pressures, respectively, but no change in transpul

259 smural filling pressure (pulmonary capillary wedge pressure - right atrial pressure), LV myocardial s

260 and it had no effect on pulmonary-capillary wedge pressure, right atrial pressure, heart rate, or ca

261 LV transmural pressure (pulmonary capillary wedge pressure-right atrial pressure), which reflects LV

262 trans-septal gradient (=pulmonary capillary wedge pressure-right atrial pressure; r=0.67; P=0.003),

263 The mean pulmonary capillary wedge pressure rose from 25+/-14 to 36+/-9 mm Hg (P:=0.0

264 in pulmonary artery and pulmonary capillary wedge pressures, suggesting abnormal compliance, with ma

265 c output, stroke volume, pulmonary capillary wedge pressure, systemic and pulmonary vascular resistan

266 g pulmonary arterial and pulmonary capillary wedge pressures than the remaining heart-failure patient

267 trated elevated exercise pulmonary capillary wedge pressure to cardiac output slope (P<0.0001) with n

268 d pulmonary arterial and pulmonary capillary wedge pressures to a greater level than OMA alone or ACE

269 ure was > 20 mm Hg; in 61.4%, end-expiratory wedge pressure was > 12 mm Hg.

270 The pulmonary artery wedge pressure was </=15 mm Hg in 54%, indicating that l

271 k 12, the change in 25-W pulmonary capillary wedge pressure was -2.8 (6.8) mm Hg in the exercise grou

272 004), and the corresponding pulmonary artery wedge pressure was 11.0 mm Hg versus 18.8 mm Hg (P=0.028

273 as 8.5 (6-18) mm Hg, and pulmonary capillary wedge pressure was 18 (14-21) mm Hg.

274 ns were 46.7+/-9.2%, and pulmonary capillary wedge pressure was 26.2+/-7.6 mm Hg.

275 L . min(-)(1) . m(-)(2), pulmonary capillary wedge pressure was 31.5 +/- 5.7 mm Hg, and heart failure

276 . kg(-)(1) . min(-)(1), pulmonary capillary wedge pressure was 5.9 +/- 4.6 mm Hg, and cardiac index

277 m Hg and between PVP and pulmonary capillary wedge pressure was 7.5 mm Hg.

278 Pulmonary capillary wedge pressure was correlated with body mass and plasma

279 vascular resistance and pulmonary capillary wedge pressure was evident at 3 min after infusion in 70

280 Mean exercise pulmonary capillary wedge pressure was lower at 6 months than at baseline, b

281 In supine position, pulmonary arterial wedge pressure was lower in discordant HFpEF at rest (15

282 In upright position, pulmonary arterial wedge pressure was lower in discordant HFpEF both at res

283 Pulmonary capillary wedge pressure was reduced from a mean of 23 mm Hg (SD 5

284 r for the two groups but pulmonary capillary wedge pressure was slightly lower for Group C (22 vs. 24

285 administration, exercise pulmonary capillary wedge pressure was substantially improved by nitrite as

286 Furthermore, pulmonary capillary wedge pressure was superior to thermodilution CI and Fic

287 espectively; and Pw referred to the coronary wedge pressure, was also measured.

288 tion with measurement of pulmonary capillary wedge pressure waveform during 5 different loading condi

289 detailed analysis of the pulmonary capillary wedge pressure waveform obtained by right-heart catheter

290 ar resistance and normal pulmonary capillary wedge pressure, we make a weak recommendation for either

291 vascular resistance and pulmonary capillary wedge pressure were decreased, as compared with untreate

292 The cardiac index and pulmonary-capillary wedge pressure were elevated in the six patients in whom

293 (r=0.947), while PVP and pulmonary capillary wedge pressure were found to be moderately correlated (r

294 ase-MB bands, troponin levels, and pulmonary wedge pressure were not elevated.

295 rtery pressure (PAP) and pulmonary capillary wedge pressure were obtained by standard techniques.

296 m, pulmonary artery, and pulmonary capillary wedge pressure were obtained in 85 patients during a tot

297 F, while pulmonary artery mean and pulmonary wedge pressures were similar.

298 displayed an increase in pulmonary capillary wedge pressure with exercise from 20+/-6 to 34+/-7 mm Hg

299 ubjects displayed higher pulmonary capillary wedge pressure with exercise, but this was solely becaus

300 diac output, and reduces pulmonary capillary wedge pressure without causing deleterious increases in